Dianthus Therapeutics, Inc. (DNTH)
45.52
+0.66
(+1.47%)
USD |
NASDAQ |
Jan 14, 15:09
Dianthus Therapeutics Market Cap: 1.952B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 7.870B |
| Lexicon Pharmaceuticals, Inc. | 450.61M |
| Day One Biopharmaceuticals, Inc. | 1.096B |
| CEL-SCI Corp. | 15.46M |
| AIM ImmunoTech, Inc. | 3.706M |
Market Cap Related Metrics
| PS Ratio | 534.03 |
| PEG Ratio | -0.3278 |
| Price to Book Value | 3.572 |
| Price | 45.52 |
| Earnings Yield | -7.67% |
| PEGY Ratio | -0.3278 |